【辉瑞(PFE.US)血友病疗法III期试验告捷 Hympavzi药物或提交上市申请】智通财经APP获悉,制药巨头辉瑞(

智通财经
26 Jun
【辉瑞(PFE.US)血友病疗法III期试验告捷 Hympavzi药物或提交上市申请】智通财经APP获悉,制药巨头辉瑞(PFE.US)周四宣布,其每周一次注射用血友病治疗药物Hympavzi在III期临床试验中取得成功,该试验针对产生因子替代疗法中和抗体的患者群体。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10